Considering that in animal studies [25] a decreased level of adipolin has been reported in an inflammatory environment, it is possible, at least in part, to infer that the presence of chronic inflammatory conditions in COPD patients affects the reduced serum levels of adipolin, which should be further investigated. This evidence concerns the gene C1QTNF12 and chronic obstructive pulmonary disease.